Sands Capital Ventures
Sands Capital is an investment manager who seeks to invest in technology and life sciences businesses from Series A through public listing..
Business Model: B2B
Revenue: $11M
Employees: 11-50
Rankings
Detailed Sands Capital Ventures Information
Geographic Data
Address: 1101 Wilson Blvd
City: Arlington
State: VA
Zip: 22209
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$837M
Social
Facebook
Linkedin
Crunchbase
Metrics
2,811,762Website Global Rank
6,109Website Monthly Traffic
Twitter Followers
Description
Sands Capital is an active, long-term investor in innovative growth businesses, globally. Our approach combines rigorous fundamental analysis with inspired thinking to seek high-quality businesses that are creating the future. We operate our business through two affiliates: Sands Capital Management, which focuses on investing in companies in public markets; and Sands Capital Ventures, which focuses on investing in companies in the private markets. By enabling our clients to participate in the growth of these businesses, our mission is to add value and enhance their wealth with prudence over time. An independent, staff-owned firm based in the Greater Washington, DC area, Sands Capital managed more than $75 billion USD in client assets as of December 31, 2020.
Contact Phone:
+17035624000
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2023 | HAWK:AI | Series B | 17M |
| 2/2022 | Speech Graphics | Series A | 7M |
| 2/2018 | BigBasket | Series E | 300M |
| 12/2020 | StockX | Series E | 275M |
| 1/2021 | Cytrellis Biosystems | Series C | 50M |
| 9/2020 | BYJU’S | Private Equity Round | 500M |
| 2/2022 | Day Zero Diagnostics | Venture Round | 0 |
| 6/2016 | Kit Check | Series C | 0 |
| 6/2022 | Papercup | Series A | 0 |
| 2/2019 | Teckro | Series C | 0 |
| 6/2021 | Primer | Series C | 0 |
| 3/2019 | PolyAI | Series A | 12M |
| 11/2021 | SafeBreach | Series D | 0 |
| 9/2021 | HUNGRY | Series C | 0 |
| 1/2017 | Funding Circle | Series F | 100M |
| 4/2021 | Biosplice Therapeutics | Venture Round | 0 |
| 9/2021 | Vesper | Venture Round | 0 |
| 11/2013 | Betable | Series A | 18.5M |
| 5/2019 | DoorDash | Series G | 600M |
| 2/2022 | Red Sift | Series B | 0 |
| 2/2022 | SeLux Diagnostics | Series C | 0 |
| 9/2021 | Snyk | Series F | 304M |
| 8/2021 | Dice Therapeutics | Series C | 60M |
| 12/2019 | ArcherDX | Series C | 0 |
| 5/2022 | Redbud Brands | Venture Round | 0 |
| 9/2015 | Modernizing Medicine | Series E | 38M |
| 10/2018 | Acumen Pharmaceuticals | Series A | 15M |
| 8/2018 | Slack | Series H | 427M |
| 12/2020 | Papercup | Funding Round | 0 |
| 1/2021 | Earli | Series A | 40M |
| 8/2020 | Qvella Corporation | Venture Round | - |
| 7/2016 | Scopely | Series B | 55M |
| 9/2022 | Vitara Biomedical | Series B | 0 |
| 11/2021 | Prilenia | Series B | 0 |
| 8/2017 | Day Zero Diagnostics | Seed Round | 3M |
| 4/2015 | Funding Circle | Series E | 150M |
| 4/2019 | Candel Therapeutics | Series C | 22.5M |
| 9/2021 | Qvella Corporation | Venture Round | - |
| 2/2018 | NepFin | Series A | 10M |
| 4/2014 | Lending Club | Private Equity Round | 65M |
| 3/2019 | Karuna Therapeutics | Series B | 0 |
| 3/2019 | Bridgit | Series A | 4.6M |
| 8/2017 | Uhnder | Series A | - |
| 7/2022 | Inspirna, Inc.(formerly Rgenix, Inc.) | Series D | 0 |
| 7/2021 | Exo | Series C | 0 |
| 10/2018 | Blackbuck | Series D | 27.5M |
| 8/2010 | Complete Genomics | Series E | 39M |
| 5/2021 | Boom Entertainment | Series A | 0 |
| 2/2019 | Health Catalyst | Series F | 0 |
| 2/2022 | Codoxo | Series B | 20M |
| 10/2021 | Bridgit | Series B | 0 |
| 6/2017 | Scopely | Series C | 60M |
| 8/2021 | #Paid | Series B | 0 |
| 8/2020 | Freenome | Series C | 270M |
| 9/2018 | Nanoview Biosciences | Series B | 10M |
| 10/2018 | WireWheel.io | Series A | 10M |
| 8/2017 | Teckro | Series B | 10M |
| 10/2011 | Firefly BioWorks | Venture Round | 2M |
| 4/2012 | Kidaptive | Seed Round | - |
| 12/2021 | Freenome | Series D | 300M |
| 9/2022 | RayzeBio | Series D | 160M |
| 11/2014 | Scopely | Series A | 35M |
| 7/2014 | AppDynamics | Series E | 70M |
| 9/2017 | BigBasket | Series E | 0 |
| 2/2021 | WireWheel.io | Series B | 20M |
| 10/2022 | Tellius | Series B | 0 |
| 7/2020 | Thrive Earlier Detection | Series B | 0 |
| 12/2018 | SeLux Diagnostics | Series B | 25M |
| 2/2020 | Spruce Biosciences | Series B | 88M |
| 9/2021 | JumpCloud | Series F | 0 |
| 4/2019 | HUNGRY | Series A | 0 |
| 5/2015 | MuleSoft | Series G | 0 |
| 1/2016 | Anaplan | Series E | 0 |
| 5/2014 | Anaplan | Series D | 100M |
| 7/2021 | Blackbuck | Series E | 0 |
| 7/2012 | Paydiant | Series B | 12M |
| 11/2020 | Acumen Pharmaceuticals | Series B | 0 |
| 7/2018 | Farcast | Series C | 40M |
| 9/2022 | Elephas | Series B | 41.5M |
| 6/2016 | Bluesight | Series C | 20.4M |
| 1/2015 | Bluesight | Series B | 12M |
| 2/2019 | Health Catalyst | Debt Financing | 0 |
| 5/2021 | Klaviyo | Series D | 320M |
| 9/2012 | Scopely | Seed Round | 8.5M |
| 12/2017 | Qvella Corporation | Series B | 0 |
| 3/2019 | Qvella Corporation | Venture Round | - |
| 3/2017 | Upgrade | Series A | 0 |
| 5/2018 | Vesper | Series B | 23M |
| 6/2020 | Outreach | Series F | 50M |
| 9/2021 | Elephas | Series A | 20M |
| 1/2022 | Nucleix | Venture Round | 22M |
| 5/2020 | Samsara | Series F | 700M |
| 1/2019 | Allvision | Seed Round | 3.2M |
| 1/2021 | Dice Therapeutics | Series C | 80M |
| 6/2017 | Avitide | Equity | 12M |
| 5/2021 | Lyra Health | Series F | 200M |
| 8/2016 | Farcast | Series B | 27.4M |
| 11/2021 | Acrivon Therapeutics | Series B | 0 |
| 8/2020 | Taysha Gene Therapies | Series B | 0 |
| 2/2021 | Personal Genome Diagnostics | Series C | 0 |
| 5/2022 | Credo AI | Series A | 0 |
| 9/2021 | PolyAI | Series A | 14M |
| 8/2021 | Gusto | Series E | 0 |
| 7/2022 | Cleerly | Series C | 0 |
| 10/2019 | Scopely | Series D | 400M |
| 10/2020 | Scopely | Series E | 340M |
| 10/2011 | Zaarly | Series A | 14.2M |
| 12/2020 | Uhnder | Series C | 0 |
| 3/2015 | Health Catalyst | Series D | 0 |
| 3/2016 | BigBasket | Series D | 150M |
| 4/2019 | UiPath | Series D | 568M |
| 5/2015 | DocuSign | Series F | 0 |
| 3/2014 | DocuSign | Series E | 85M |
| 11/2021 | SafeRide Health | Series B | - |
| 11/2015 | AppDynamics | Series F | 0 |
| 12/2020 | Coagulo Medical Technologies | Venture Round | 6.5M |
| 12/2022 | Snyk | Series G | 0 |
| 6/2021 | Outreach | Series G | 0 |
| 7/2020 | Bridgit | Venture Round | 7M |
| 12/2020 | Brightflag | Equity | 28M |
| 5/2019 | Blackbuck | Series D | 150M |
| 11/2021 | Ankyra | Series B | 45M |
| 4/2019 | 908 Devices | Series E | 17.5M |
| 6/2013 | Bluesight | Series A | 10.4M |
| 6/2021 | Nubank | Series G | 0 |
| 9/2019 | DataRobot | Series E | 206M |
| 10/2015 | Qvella Corporation | Series A | 20M |
| 2/2020 | Globalization Partners | Private Equity Round | 0 |
| 10/2015 | Opinio | Series A | 7M |
| 12/2012 | Stipple | Venture Round | 3M |
| 12/2012 | Modernizing Medicine | Series B | 12M |
| 3/2023 | pgEdge | Seed Round | 9M |
| 5/2022 | LimaCharlie | Seed Round | 0 |
| 2/2017 | Agilis Biotherapeutics | Venture Round | 12.7M |
| 10/2017 | BigBasket | Venture Round | 0 |
| 8/2018 | Upgrade | Series C | 0 |
| 11/2015 | Quad Technologies | Series A | 3M |
| 4/2019 | Brightflag | Series A | 7.9M |
| 11/2021 | Upgrade | Series F | 0 |
| 11/2021 | Mekonos | Series A | 0 |
| 7/2021 | Wugen | Series B | 0 |
| 4/2021 | Tellius | Series A | 8M |
| 3/2017 | Blackbuck | Series C | 70M |
| 9/2020 | Totient | Seed Round | 0 |
| 9/2012 | Genometry | Series A | 3M |
| 7/2022 | Cleerly | Series C | 0 |
| 7/2022 | Inspirna, Inc.(formerly Rgenix, Inc.) | Series D | 0 |
| 6/2022 | Papercup | Series A | 0 |
| 5/2022 | LimaCharlie | Seed Round | 0 |
| 5/2022 | Redbud Brands | Venture Round | 0 |
| 5/2022 | Credo AI | Series A | 0 |
| 2/2022 | SeLux Diagnostics | Series C | 0 |
| 2/2022 | Red Sift | Series B | 0 |
| 2/2022 | Speech Graphics | Series A | 0 |
| 2/2022 | Day Zero Diagnostics | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
